The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study).
Juan ZhaoWei ZhouYangfeng WuPing JiLi YangXiaoyan YanZhuoli ZhangPublished in: BMC Medical Informatics Decis. Mak. (2021)